Supplementary Tables S1-S6 and Supplementary Figures S1-S2 from BGB-283, a Novel RAF Kinase and EGFR Inhibitor, Displays Potent Antitumor Activity in &lt;i&gt;BRAF&lt;/i&gt;-Mutated Colorectal Cancers